Preconditioning by mitochondrial ATP-sensitive potassium channel openers: An effective approach for improving the preservation of heart transplants

Circulation

Volumn 100, Issue 19 SUPPL., 1999, Pages

  Kevelaitis, Egidijus ^b   Oubénaïssa, Abdeslam ^a   Peynet, Jacqueline ^a   Mouas, Christian ^a   Menasché, Philippe ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

Author keywords

Diastole; Ischemia; Reperfusion; Systole; Vasodilation

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE KINASE; DIAZOXIDE; ION CHANNEL; POTASSIUM CHANNEL; POTASSIUM CHANNEL AFFECTING AGENT;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIASTOLE; HEART MITOCHONDRION; HEART MUSCLE REPERFUSION; HEART TRANSPLANTATION; MALE; MITOCHONDRION; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RAT; SYSTOLE; VASODILATATION;

EID: 0344771169     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.cir.100.suppl_2.ii-345     Document Type: Article

References (29)

1. Saitoh Y, Gu K, Kin S, Yamauchi M, Sasaki T, Nosaka S, Hashimoto M, Nakayama K, Tamura K. Ischemic preconditioning improves cardiac functional recovery following preservation with University of Wisconsin solution. Transplantation. 1995;60:1079-1083.
2. Ogino H, Smolenski RT, Zych M, Seymour AM, Yacoub MH. Influence of preconditioning on rat heart subjected to prolonged cardioplegic arrest. Ann Thorac Surg. 1996;62:469-474.
3. Karck M, Rahmanian P, Haverich A. Ischemic preconditioning enhances donor heart preservation. Transplantation. 1996;62:17-22.
4. Perrault LP, Menasché P, Bel A, Chaumaray T, Peynet J, Mondry A, Olivero P, Emanoil-Ravier R, Moalic J-M. Ischemic preconditioning in cardiac surgery: a word of caution. J Thorac Cardiovasc Surg. 1996;112: 1378-1386.
5. Parratt JR. Possibilities for the pharmacological exploitation of ischemic preconditioning. J Mol Cell Cardiol. 1995;27:991-1000.
6. Menasché P. New strategies in myocardial preservation. Curr Opin Cardiol. 1997;12:504-514.
7. ATP channels meet the requirements? Basic Res Cardiol. 1996;91:31-34.
8. + blocker dofetilide. Am J Physiol. 1996;271:H1207-H1214.
9. ATP opener cromakalim is not correlated with ischemic myocardial action potential duration. J Cardiovasc Pharmacol. 1995;26:145-152.
10. ATP channel. Am J Physiol. 1996;40: H1769-H1777.
11. + channel in the mitochondrial inner membrane. Nature. 1991;352:244-247.
12. Liu Y, Sato T, O'Rourke B, Marban E. Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation. 1998;97:2463-2470.
13. + channels: possible mechanism of cardioprotection. Circ Res. 1997;81:1072-1082.
14. Baines CP, Liu GS, Birincioglu M, Cohen MV, Downey JM. Diazoxide, a mitochondrial KATP-channel opener, is cardioprotective in ischemic rabbit myocardium. Circulation. 1998;98(suppl I):I-343. Abstract.
15. Menasché P, Termignon J-L, Pradier F, Grousset C, Mouas C, Alberici G, Weiss M, Piwnica A, Bloch G. Experimental evaluation of Celsior, a new heart preservation solution. Eur J Cardiothorac Surg. 1994;8:207-213.
16. ATP channel as a receptor for potassium channel openers. J Biol Chem. 1996;271:8796-8799.
17. + channels by protein kinase C. Circ Res. 1998;83:110-114.
18. m overload in rat hearts. Am J Physiol. 1996;271:H2145-H2153.
19. 0 ATPase. Circulation. 1995;91:2810-2818.
20. Steenbergen C, Perlman ME, London RE, Murphy E. Mechanism of preconditioning: ionic alterations. Circ Res. 1993;72:112-125.
21. +-ATPase activity reduces the infarct size-limiting effect of preconditioning in rabbit hearts. Circulation. 1997;96:599-604.
22. Ovize M, Kloner RA, Przyklenk K. Preconditioning and myocardial contractile function. In: Przyklenk K, Kloner RA, Yellon DM, eds. Ischemic Preconditioning: The Concept of Endogenous Cardioprotection. Boston Mass: Kluwer Academic Publishers; 1994:41-60.
23. 2+ responsiveness and altered diastolic function in intact ventricular muscle. Circ Res. 1995;76: 1036-1048.
24. Sun JS, Kaur H, Halliwell B, Li XY, Bolli R. Use of aromatic hydroxylation of phenylalanine to measure production of hydroxyl radicals after myocardial ischemia in vivo: direct evidence for a pathogenetic role of the hydroxyl radical in myocardial stunning. Circ Res. 1993;73:534-549.
25. Pietri S, Culcasi M, Albat B, Albérici G, Menasché P. Direct assessment of the antioxidant effects of a new heart preservation solution. Celsior: a hemodynamic and electron spin resonance study. Transplantation. 1994; 58:740-742.
26. Bauer B, Simkhovich BZ, Kloner RA, Pryklenk K. Does preconditioning protect the coronary vasculature from subsequent ischemia/reperfusion injury? Circulation. 1993;88:659-672.
27. Shirai T, Rao V, Weisel RD. Preconditioning human cardiomyocytes and endothelial cells. J Thorac Cardiovasc Surg. 1998;115:210-219.
28. Kevelaitis E, Mouas C, Menasché P. Poststorage diastolic abnormalities of heart transplants: is vascular dysfunction or myocardial contracture the culprit? J Heart Lung Transplant. 1996;15:461-469.
29. Downey JM, Cohen MV. Signal transduction in ischemic preconditioning. Adv Exp Med Biol. 1997;430:39-55.